Calyx, ProTrials partner to improve clinical trial data management
Calyx has been designated as a partner of the clinical research organization ProTrials Research to strengthen its capabilities for production of strong and well-managed clinical trial outcomes data using Calyx's eClinical solutions. Read More
Axion BioSystems acquires Cytosmart Technologies
Life sciences firm Axion BioSystems has acquired Netherlands-based Cytosmart, a company specializing in kinetic live-cell imaging analysis. Read More
Twist launches synthetic RNA capsules
Twist Bioscience has launched synthetic RNA positive controls for SARS-CoV-2 encapsulated in proprietary stainless steel minicapsules provided by Imagene SA. Read More
Triumvira completes extension of series A financing
Triumvira Immunologics has completed an extension of its series A financing, bringing the total round to approximately $100 million. Read More
NIH's All of Us Research Program releases first genomic dataset
The National Institutes of Health (NIH) has made nearly 100,000 highly diverse whole genome sequences, including approximately 50% from individuals that have historically been underrepresented in research, available through its All of Us Research Program. Read More
HitGen to collaborate with HHMI, Duke
China's HitGen has entered a research collaboration agreement with the Howard Hughes Medical Institute (HHMI) and Duke University over the use of the company's OpenDEL DNA-encoded library (DEL). Read More
InSitu Biologics welcomed into UAE in5 Incubator
Oakdale, MI-based InSitu Biologics has been welcomed into in5, one of the United Arab Emirates' leading incubators, which specializes in supporting tech, media, and design startups. Read More
BeiGene wins expanded approval for tislelizumab in China
BeiGene has received a new conditional approval from the China National Medical Products Administration for its tislelizumab anti-programmed cell death 1 monoclonal antibody. Read More
GeneDx publishes data on genetic conditions
GeneDx has published 200 new and expanded genetic conditions in the journal Human Mutation. The article outlines the firm's contributions to GeneMatcher, a genomic database designed to enable connections between clinicians and researchers. Read More
Illumina Accelerator invests in 7 genomics startups
Illumina has invested in seven new genomics companies to join the fourth global funding cycle of Illumina Accelerator San Francisco Bay Area and Cambridge, U.K. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
